CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-14 | Jacobs John C President, CEO | Sale | −12,456 | $42.06 | $524K | 12,544 |
| 2022-03-14 | Jacobs John C President, CEO | Sale | −11,614 | $42.66 | $495K | 930 |
| 2022-03-14 | Jacobs John C President, CEO | Sale | −930 | $43.47 | $40K | 0 |
| 2022-03-14 | Jacobs John C President, CEO | Exercise or conversion · Stock Option | −25,000 | 209,751 | ||
| 2022-03-11 | Wicki Andreas Director | Sale | −70,370 | $44.14 | $3.1M | 3,663,228 |
| 2022-03-10 | Wicki Andreas Director | Sale | −75,217 | $45.80 | $3.4M | 3,733,598 |
| 2022-03-09 | Wicki Andreas Director | Sale | −140,000 | $45.49 | $6.4M | 3,808,815 |
| 2022-03-03 | Wicki Andreas Director | Sale | −175,000 | $41.01 | $7.2M | 3,948,815 |
| 2022-03-02 | Wicki Andreas Director | Sale | −328,927 | $40.52 | $13.3M | 4,123,815 |
| 2022-03-01 | Wicki Andreas Director | Sale | −92,501 | $40.24 | $3.7M | 4,452,742 |
| 2022-03-01 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +4,869 | $8.22 | $40K | 4,869 |
| 2022-03-01 | Dierks Jeffrey Chief Commercial Officer | Sale | −4,869 | $40.04 | $195K | 0 |
| 2022-03-01 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −4,869 | 14,607 | ||
| 2022-02-28 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +10,041 | $24.00 | $241K | 10,041 |
| 2022-02-28 | Dierks Jeffrey Chief Commercial Officer | Sale | −10,041 | $40.00 | $402K | 0 |
| 2022-02-28 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −10,041 | 130,556 | ||
| 2022-02-17 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +200 | $24.00 | $5K | 200 |
| 2022-02-17 | Dierks Jeffrey Chief Commercial Officer | Sale | −4,259 | $40.02 | $170K | 0 |
| 2022-02-17 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −200 | 140,397 | ||
| 2022-02-16 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +4,259 | $24.00 | $102K | 4,259 |
Page 19 of 26 · 511 trades